drugset / Trial / NCT01411930

Acute Impact of Intramuscular (IM) Aripiprazole and Olanzapine on Insulin Resistance in High Risk Prediabetics

NCT01411930

RandomizedCrossoverOpen-labelBasic science

Summary

Antipsychotic medicines used to treat mental illnesses have been associated with effects on blood sugar control. Laboratory studies have shown that certain medications in particular may alter how insulin works. One purpose of this study is determine if antipsychotic medications have immediate effects on insulin action in individuals who do not have a mental disorder, but who have risk factors for diabetes. A second purpose is to demonstrate the feasibility of using volunteers without psychiatric disorders, and who do not take psychiatric medications, as a means for studying antipsychotic metabolic effects.

Timeline

Start
2009-03
Primary completion
2010-03
Completion
2011-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Aripiprazole Other / unclassified 9.75 mg Intramuscular
Subject Olanzapine Small molecule 10 mg Intramuscular

Indications